Thilo Schroeder, Director at PMV Pharmaceuticals, Inc. (PMVP), sold 103,008 shares at $30.66 ($3.2M) on 2021-08-23, disclosed to the SEC on 2021-08-25.
Open-market sale of $3.2M PMVP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $30.66 | 23,138 | $709K | 22.3% |
| 2 | $30.66 | 23,138 | $709K | 22.3% |
| 3 | $31.06 | 700 | $22K | 0.7% |
| 4 | $31.08 | 14,490 | $450K | 14.2% |
| 5 | $31.08 | 14,490 | $450K | 14.2% |
| 6 | $31.01 | 13,526 |
| $419K |
| 13.2% |
| 7 | $31.01 | 13,526 | $419K | 13.2% |
| Total | $30.87 avg | 103,008 | $3.2M | 100% |
| Filing → |
| RVMD | BUY | 2022-07-26 | $5.0M | — | Filing → |
| RVMD | BUY | 2022-03-29 | $2.1M | — | Filing → |
| RVMD | BUY | 2022-03-24 | $11.0M | — | Filing → |